Strong EGFR signaling in cell line models of ERBB2-amplified breast cancer attenuates response towards ERBB2-targeting drugs

Frauke Henjes(Heidelberg University), Ulrike Korf(German Cancer Research Center)
Oncogenesis
July 2, 2012
Cited by 84


Related Papers